Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1.

Geffin RB, Scott GB, Melenwick M, Hutto C, Lai S, Boots LJ, McKenna PM, Kessler JA 2nd, Conley AJ.

AIDS Res Hum Retroviruses. 1998 May 1;14(7):579-90.


Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.

Boots LJ, McKenna PM, Arnold BA, Keller PM, Gorny MK, Zolla-Pazner S, Robinson JE, Conley AJ.

AIDS Res Hum Retroviruses. 1997 Dec 10;13(18):1549-59.


The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.

Conley AJ, Kessler JA 2nd, Boots LJ, McKenna PM, Schleif WA, Emini EA, Mark GE 3rd, Katinger H, Cobb EK, Lunceford SM, Rouse SR, Murthy KK.

J Virol. 1996 Oct;70(10):6751-8.


Enhancing the avidity of a human recombinant anti-HIV-1 monoclonal antibody through oligomerization.

Tsai PK, Burke CJ, Irwin JW, Bruner MW, Tung JS, Hollis GF, Mark GE, Kessler JA 2nd, Boots LJ, Conley AJ, et al.

J Pharm Sci. 1995 Jul;84(7):866-70.


A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.

Yasutomi Y, Koenig S, Woods RM, Madsen J, Wassef NM, Alving CR, Klein HJ, Nolan TE, Boots LJ, Kessler JA, et al.

J Virol. 1995 Apr;69(4):2279-84.


Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.

Koenig S, Conley AJ, Brewah YA, Jones GM, Leath S, Boots LJ, Davey V, Pantaleo G, Demarest JF, Carter C, et al.

Nat Med. 1995 Apr;1(4):330-6.


A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Moore JP, Trkola A, Korber B, Boots LJ, Kessler JA 2nd, McCutchan FE, Mascola J, Ho DD, Robinson J, Conley AJ.

J Virol. 1995 Jan;69(1):122-30.


Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

Gorny MK, Moore JP, Conley AJ, Karwowska S, Sodroski J, Williams C, Burda S, Boots LJ, Zolla-Pazner S.

J Virol. 1994 Dec;68(12):8312-20.


Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D.

Conley AJ, Gorny MK, Kessler JA 2nd, Boots LJ, Ossorio-Castro M, Koenig S, Lineberger DW, Emini EA, Williams C, Zolla-Pazner S.

J Virol. 1994 Nov;68(11):6994-7000.


Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

Conley AJ, Kessler JA 2nd, Boots LJ, Tung JS, Arnold BA, Keller PM, Shaw AR, Emini EA.

Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3348-52.

Supplemental Content

Loading ...
Support Center